Cancellations and suspensions
This database records details of medicines and medical devices that have been cancelled or suspended, and no longer appear in the ARTG.
Following a review by the TGA, complementary medicines can be cancelled from the Australian Register of Therapeutic Goods. These cancellations are made by the Secretary under section 30 of the Therapeutic Goods Act 1989.
Where other actions are taken in relation to safety, a link to the TGA's safety alert will be included in the database under 'Further information'.
The reasons for a cancellation are stated in the database below under 'Grounds for cancellation'.
The heading 'Decision status' provides updated information about cancellation decisions, for example information about any decision to revoke a cancellation decision. It will not appear in every entry.
To find out whether a product is currently authorised for supply in Australia, check the ARTG.
Last updated
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Action
- Medicine suspension (74)
- Medical device cancellation (63)
- Medical device cancellation - certain devices within an entry (9)
- Voluntary revocation at the request of the manufacturer (9)
- Revocation of a TGA issued Conformity Assessment Certificate (8)
- Medical device cancellation (7)
- Listed medicine cancellation (3)
- Listed medicine cancellation (3)
- Revocation of medical device suspension (2)
- Revoked medicine suspension (2)
- Alphapharm Pty Ltd (1)
- Complementary medicine cancellation (1)
- Medical device cancellation (1)
- Medical device suspension (1)
- Medicine cancellation (1)
- Suspension from the ARTG under subsection s41GA(1)(b) (1)
Find out more about Cancellations and Suspensions.
Search
191 result(s) found, displaying 76 to 100
-
Cancellation or suspensionThe sponsor did not provide sufficient information to substantiate compliance with the Essential Principles, the sponsor failed to comply with a condition to which inclusion of the kind of device in the ARTG was subject.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/07/2024
-
Cancellation or suspensionThe device was Suspended under section 41GA of the Act, and the period of suspension of the Device from the ARTG has expired. Therefore, the suspended ARTG must be cancelled as per section 41GK of the Act, effective 21/06/2024
-
Cancellation or suspensionThe device was Suspended under section 41GA of the Act, and the period of suspension of the Device from the ARTG has expired. Therefore, the suspended ARTG must be cancelled as per section 41GK of the Act, effective 24/06/2024
-
Cancellation or suspensionThe device was Suspended under section 41GA of the Act, and the period of suspension of the Device from the ARTG has expired. Therefore, the suspended ARTG must be cancelled as per section 41GK of the Act., effective 21/06/2024
-
Cancellation or suspensionRegulatory action due to Under paragraph 41FA(1)(b); the conformity assessment certification applying to the Device has been suspended by the Notified Body, effective 1/05/2024
-
Cancellation or suspensionThe devices were Suspended under section 41GA of the Act, and the period of suspension of the Device from the ARTG has expired. Therefore, the suspended ARTG must be cancelled as per section 41GK of the Act., effective 21/06/2024
-
Cancellation or suspensionThe devices were Suspended under section 41GA of the Act, and the period of suspension of the Device from the ARTG has expired. Therefore, the suspended ARTG must be cancelled as per section 41GK of the Act, effective 21/06/2024
-
Cancellation or suspensionThe delegate is satisfied that the requirements of section 41GD of Act are met and I am revoking the suspension of the Device from the ARTG., effective 21/06/2024
-
Cancellation or suspensionThe delegate is satisfied that the requirements of section 41GD of Act are met and I am revoking the suspension of the Device from the ARTG., effective 21/06/2024
-
Cancellation or suspensionThe device was Suspended under section 41GA of the Act, and the period of suspension of the Device from the ARTG has expired. Therefore, the suspended ARTG must be cancelled as per section 41GK of the Act., effective 21/06/2024
-
Cancellation or suspensionThe sponsor has refused or failed to comply with a condition to which the inclusion of the goods is subject (paragraph 30(2)(c) of the Act).
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/06/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 17/06/2024
Last updated